Chen-Lin Hsieh, Ph.D.
Affiliations: | 2010 | Biology (Cell-Molecular Biology) | The University of Toledo |
Area:
Molecular BiologyGoogle:
"Chen-Lin Hsieh"Parents
Sign in to add mentor| Lirim Shemshedini | grad student | 2010 | The University of Toledo | |
| (The pro-cancer function of soluble guanylate cyclase alpha-1 (sGCalpha1) in prostate cancer progression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gui B, Hsieh CL, Kantoff PW, et al. (2017) Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer. Plos One. 12: e0184166 |
| Zhou J, Gao S, Hsieh CL, et al. (2017) Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells. Plos One. 12: e0184088 |
| Hsieh CL, Botta G, Gao S, et al. (2015) PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy. Cancer Research. 75: 1944-8 |
| Hsieh CL, Fei T, Chen Y, et al. (2014) Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proceedings of the National Academy of Sciences of the United States of America. 111: 7319-24 |
| Gao S, Hsieh CL, Zhou J, et al. (2013) Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells. Plos One. 8: e78766 |
| Gao S, Hsieh CL, Bhansali M, et al. (2013) A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer. Plos One. 8: e64189 |
| Nguyen HC, Xie W, Yang M, et al. (2013) Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. The Prostate. 73: 346-54 |
| Cai C, Hsieh CL, Gao S, et al. (2012) Soluble guanylyl cyclase α1 and p53 cytoplasmic sequestration and down-regulation in prostate cancer. Molecular Endocrinology (Baltimore, Md.). 26: 292-307 |
| Sun T, Yang M, Chen S, et al. (2012) The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer. The Prostate. 72: 1093-103 |
| Hsieh CL, Cai C, Giwa A, et al. (2008) Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells. Journal of Molecular Endocrinology. 41: 13-23 |